Rosuvastatin side effects in women
Pro Research Analysisby 
Searched over 200M research papers
Common Rosuvastatin Side Effects in Women
Research shows that women taking rosuvastatin can experience a range of side effects. The most frequently reported issues include dizziness, pruritus (itchy skin), pain, nausea, fatigue, myalgia (muscle pain), diarrhea, dyspnea (shortness of breath), headache, and weakness. Studies indicate that women may be more susceptible to these adverse effects compared to men, especially when rosuvastatin is combined with other lipid-lowering drugs like fenofibrate 123.
Dizziness and Pruritus: Case Reports in Women
Several case reports specifically highlight dizziness and pruritus as notable side effects in women starting rosuvastatin. In these cases, symptoms appeared within 10 to 14 days of beginning the medication and resolved after discontinuation. This suggests a clear link between rosuvastatin use and these symptoms in some women 12.
Serious Adverse Effects: Rhabdomyolysis and Renal Failure
Though rare, serious side effects such as rhabdomyolysis (severe muscle breakdown) and acute renal failure have been reported in women, particularly in those with genetic variations that slow rosuvastatin metabolism or in those prescribed high doses. Older age, impaired kidney function, and concurrent illnesses or medications can further increase this risk. Genetic testing for certain metabolic enzymes may help identify women at higher risk for these severe reactions .
Muscular and Gastrointestinal Side Effects
Women are generally more likely to experience muscular side effects (like myalgia and weakness) and gastrointestinal symptoms (such as nausea and diarrhea) when taking rosuvastatin, especially in combination therapies. These findings highlight the importance of monitoring for these symptoms and adjusting treatment as needed .
Rosuvastatin Compared to Other Statins in Women
In heart transplant patients, rosuvastatin was found to be more effective at lowering cholesterol without increasing the prevalence or severity of side effects compared to other statins. This suggests that, for some women, rosuvastatin may be a well-tolerated option, but individual responses can vary .
Effects on Female Reproductive Physiology
Animal studies suggest that rosuvastatin can alter uterine contractility in female rats, though it does not appear to have direct estrogenic or antiestrogenic effects. The clinical significance of these findings in women is not yet clear, but they indicate a potential for rosuvastatin to affect reproductive physiology through mechanisms unrelated to hormone signaling .
Conclusion
Women taking rosuvastatin may experience side effects such as dizziness, pruritus, muscle pain, and gastrointestinal symptoms, with some evidence suggesting a higher susceptibility compared to men. Rare but serious risks like rhabdomyolysis and kidney injury are also possible, especially in those with certain genetic backgrounds or other risk factors. Regular monitoring and individualized treatment are important to minimize adverse effects and ensure safe use of rosuvastatin in women.
Sources and full results
Most relevant research papers on this topic